Our results were consistent with these observations that CCNE1 was upregulated in MYCN-amplified paediatric neuroblastoma patients, and CCNE1 overexpression was associated with worse clinical outcomes of paediatric neuroblastoma. Here, MYCN is linked to neuroblastoma.